Beta-Alanine
Also sold as: Beta alanine · 3-Aminopropanoic acid
An amino acid used to raise muscle carnosine for sustained high-intensity exercise. It requires loading rather than acting as an acute stimulant.
Energy
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Energy: Small benefit for sustained high-intensity exercise, especially 1-4 minutes; not an immediate stimulant or treatment for everyday fatigue.
REALITY CHECK // Meta-analyses in healthy adults find a small exercise benefit (effect size 0.18, 95% CI 0.08-0.28), stronger for capacity than competition-like performance. The useful window is mainly sustained high-intensity work around 1-4 minutes after weeks of supplementation. Repeated short sprints, maximal strength and muscle growth are not reliably improved.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
UPPER LIMIT // No formal nutrient UL is established in the supplied dossier. Large single portions increase transient tingling; absence of an UL does not establish unlimited safety. The extraction contains contradictory verification notes for its safety-assessment citation.
Summary
Meta-analyses in healthy adults find a small exercise benefit (effect size 0.18, 95% CI 0.08-0.28), stronger for capacity than competition-like performance. The useful window is mainly sustained high-intensity work around 1-4 minutes after weeks of supplementation. Repeated short sprints, maximal strength and muscle growth are not reliably improved.
Mechanism
Beta-alanine raises muscle carnosine, which buffers hydrogen ions during intense exercise. Cumulative exposure drives muscle loading; tingling is a sensory side effect, not an efficacy marker.
Typical studied dose
Human protocols commonly used 3.2-6.4 g/day for 4-12 weeks, often divided into portions no larger than 1.6 g. These are studied exposures, not a universal dosing instruction.
Upper limit
No formal nutrient UL is established in the supplied dossier. Large single portions increase transient tingling; absence of an UL does not establish unlimited safety. The extraction contains contradictory verification notes for its safety-assessment citation.
Popular stacks with Beta-Alanine
Not enough stack data yet. A combination with Beta-Alanine appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| Immediate-release beta-alanine Best for: Lower-cost loading. |
100% elemental / active | 3200–6400 mg | Rapid uptake; plasma peaks around 30-45 minutes. Tingling can occur around 0.8-1.6 g per portion. |
Studied standard [CHECK // MATERIAL_AND_LABEL] 100% refers to declared beta-alanine, excluding tablet excipients. Daily cumulative exposure matters more than workout timing. |
| Sustained-release beta-alanine Best for: Comfort when rapid-release portions cause tingling. |
100% elemental / active | 3200–6400 mg | Lower peak concentration with comparable loading at matched daily exposure. Usually less tingling than immediate release. |
Good option [CHECK // MATERIAL_AND_LABEL] Improved tolerability does not establish superior exercise efficacy. Enter the declared beta-alanine ingredient amount. |
Common label traps
- TRAP_01 // Tingling means it works
Tingling reflects a sensory response, not performance benefit; release characteristics change the sensation. - TRAP_02 // One pre-workout serving gives instant energy
Trials use chronic muscle loading over weeks. An acute sensation does not establish improved performance. - TRAP_03 // It builds muscle and improves every sprint
Body-composition results are uncertain; repeated short sprints differ from continuous high-intensity work.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- MUSCLE CARNOSINE Strong · benefit
Dose-response evidence supports muscle-carnosine loading; this is a mechanism, not a patient-important outcome.
PMID 32922303 - REPEATED SPRINTS Limited · no benefit
A 2026 synthesis reports no repeated-sprint benefit; its abstract was unavailable in source preparation.
PMID 41971372 - BODY COMPOSITION Limited · no benefit
Results are inconsistent; direct anabolic benefit is not established.
PMID 35813845 - MEMORY Limited · no benefit
Pooled histidine-dipeptide evidence mainly concerns carnosine/anserine and cannot establish a beta-alanine nootropic effect.
PMID 38013229 - GLYCEMIC MARKERS Limited · benefit
Preliminary carnosine/beta-alanine signals involve dysglycemic populations and animal data, not a general healthy-athlete benefit.
PMID 34333586 - OLDER-ADULT FUNCTION Limited · benefit
Five studies involving 163 older adults around age 69 show mixed exercise and functional results.
PMID 39724872
Reader questions
Does no tingling mean it failed?
No. Loading depends on cumulative exposure; tingling depends on concentration peaks and release characteristics.
Does it help low-repetition lifting?
Evidence is strongest for sustained high-intensity work around 1-4 minutes, rather than maximal strength.
Is long-term use proven safe?
Long-term evidence is limited. Contradictory safety-citation status in the extraction prevents blanket safety claims.
Stack interactions
- Caution Creatine [CAUTION // CONTEXT_MATTERS]
Evidence for added benefit is mixed. Complementary mechanisms do not prove synergy. - Caution Taurine [CAUTION // CONTEXT_MATTERS]
Shared transport creates a theoretical animal-data concern. Clinically important depletion or a need for preventive taurine has not been established. - Caution Glucose-lowering medicines [CAUTION // CONTEXT_MATTERS]
Metabolic signals in dysglycemic populations suggest theoretical additivity; a clinically important interaction is not established.
PMID 34333586
Red flags: interactions and who should avoid it
Interactions
Creatine combinations have mixed evidence for added benefit. Sodium bicarbonate may offer complementary buffering, but its catalog title is absent here. Taurine-transporter competition is a preclinical concern, not an established need to add taurine. Glucose-drug additivity is theoretical.
Avoid or ask a doctor first if
Pregnancy, breastfeeding and children lack adequate safety data. Persistent or unusual numbness should not be dismissed as supplement tingling, especially with an existing neurological condition. Transient tingling is more common with larger single portions.
Sources (PubMed, 12)
- β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis.
PMID 27797728 · 2017 · Journal Article; Meta-Analysis; Systematic ReviewContext on the specific material, mechanism or safety topic named in the indexed title; no independent claim verification was performed for this translation.
- Effects of β-alanine supplementation on exercise performance: a meta-analysis.
PMID 22270875 · 2012 · Journal Article; Meta-AnalysisContext on the specific material, mechanism or safety topic named in the indexed title; no independent claim verification was performed for this translation.
- Ergogenic Aids to Improve Physical Performance in Female Athletes: A Systematic Review with Meta-Analysis.
PMID 36615738 · 2022 · Meta-Analysis; Systematic Review; Journal ArticleContext on the specific material, mechanism or safety topic named in the indexed title; no independent claim verification was performed for this translation.
- The Muscle Carnosine Response to Beta-Alanine Supplementation: A Systematic Review With Bayesian Individual and Aggregate Data E-Max Model and Meta-Analysis.
PMID 32922303 · 2020 · Systematic Review; Journal ArticleDose-response evidence supports muscle-carnosine loading; this is a mechanism, not a patient-important outcome.
- No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials.
PMID 41971372 · 2026 · Journal Article; Systematic ReviewA 2026 synthesis reports no repeated-sprint benefit; its abstract was unavailable in source preparation.
- Effects of beta-alanine supplementation on body composition: a GRADE-assessed systematic review and meta-analysis.
PMID 35813845 · 2022 · Journal Article; Meta-Analysis; Systematic ReviewResults are inconsistent; direct anabolic benefit is not established.
- Histidine-containing dipeptide supplementation improves delayed recall: a systematic review and meta-analysis.
PMID 38013229 · 2024 · Journal Article; Systematic Review; Meta-AnalysisPooled histidine-dipeptide evidence mainly concerns carnosine/anserine and cannot establish a beta-alanine nootropic effect.
- Effect of Carnosine or β-Alanine Supplementation on Markers of Glycemic Control and Insulin Resistance in Humans and Animals: A Systematic Review and Meta-analysis.
PMID 34333586 · 2021 · Journal Article; Meta-Analysis; Research Support; Non-U.S. Gov't; Systematic ReviewPreliminary carnosine/beta-alanine signals involve dysglycemic populations and animal data, not a general healthy-athlete benefit.
- Beta-Alanine for Improving Exercise Capacity, Muscle Strength, and Functional Performance of Older Adults: A Systematic Review.
PMID 39724872 · 2025 · Journal Article; Systematic ReviewFive studies involving 163 older adults around age 69 show mixed exercise and functional results.
- Individual Participant Data Meta-Analysis Provides No Evidence of Intervention Response Variation in Individuals Supplementing With Beta-Alanine.
PMID 34098531 · 2021 · Journal Article; Meta-AnalysisContext on the specific material, mechanism or safety topic named in the indexed title; no independent claim verification was performed for this translation.
- Effect of slow-release β-alanine tablets on absorption kinetics and paresthesia.
PMID 22139410 · 2012 · Journal Article; Randomized Controlled Trial; Research Support; Non-U.S. Gov'tContext on the specific material, mechanism or safety topic named in the indexed title; no independent claim verification was performed for this translation.
- Dosing strategies for β-alanine supplementation in strength and power performance: a systematic review.
PMID 40995761 · 2025 · Journal Article; Systematic ReviewContext on the specific material, mechanism or safety topic named in the indexed title; no independent claim verification was performed for this translation.
Community comments
No approved comments yet. Comments are held for moderation.